HIV与阿片类药物协同破坏大脑DNA修复机制,已获批药物DMF在动物模型中恢复修复功能
Researchers find potential way to protect the brain from HIV and opioid damage
《Cell Death and Disease》发表的研究发现,HIV蛋白Tat与吗啡共同作用会破坏大脑的自然DNA修复系统,引发持续性炎症和认知障碍。研究人员测试了已获FDA批准的抗多发性硬化症药物二甲基富马酸酯(DMF),在实验室模型中成功恢复了DNA修复组织能力并抑制有害免疫信号。研究团队表示正计划开展人体组织验证及临床试验,探索该药用于HIV相关认知问题的潜力。
研究揭示HIV与阿片类药物治疗共同通过干扰DNA修复导致脑损伤的机制,已获批药物DMF在动物模型中恢复修复能力,为临床转化提供新思路。
People living with HIV continue to struggle with memory loss, difficulty concentrating and poor decision-making, even as antiretroviral treatments have dramatically improved life expectancy. For patients who also use opioids—which may be prescribed to manage the chronic pain that can accompany HIV—these cognitive problems can be even worse. Until now, scientists haven't understood exactly why.
Texas A&M Health researchers say they've uncovered a key factor in HIV- and opioid-use-related cognitive impairment—and it could point to a promising new way to protect the brain.
In a new study, published in Cell Death and Disease, the research team revealed that HIV and opioids combine to disrupt the brain's natural DNA repair system. This damage leads to ongoing inflammation and cognitive impairment. But the researchers believe an existing drug, approved by the Food and Drug Administration (FDA), might help reverse the effects.
People living with HIV are more likely to experience chronic pain than the general population. Between 21% and 53% are prescribed opioids to manage pain associated with HIV, aging or the side effects of other medications. Opioids also intersect with HIV through injection drug use. Sharing needles or other injection equipment when using opioids such as heroin can transmit HIV, contributing to the overlap between the two conditions.
Dr. Karthick Chennakesavan, the study's first author and assistant research scientist at the Texas A&M University Irma Lerma Rangel College of Pharmacy at Texas A&M Health, said the combination of HIV and opioids is more than just the sum of their individual effects.
"Our findings show that HIV and opioids don't just pile onto inflammation independently—they actually change the way the brain works at its most basic level," Chennakesavan said. "By finding out how this happens, we hope to create new treatments that keep brains healthier longer."
A cycle of DNA damage and inflammation
It's long been known that HIV can cause neurological problems, and opioid use can magnify them. But until now, the underlying mechanisms were unclear.
To solve the puzzle, Dr. Samikkannu Thangavel, associate professor at the Rangel College of Pharmacy who led the research team, and his colleagues examined lab-grown microglia (immune cells of the brain), genetically modified mice carrying selected HIV genes and postmortem brain tissues from people who lived with HIV.
They discovered that the HIV protein Tat (trans-activator of transcription) and morphine (a potent opiate) work together to trigger the brain's response to DNA damage while disrupting the cellular processes that organize and repair DNA. Morphine further amplified these effects, contributing to ongoing DNA damage, changes in epigenetic markers and the activation of immune pathways. Together, these changes contributed to chronic inflammation and impaired nerve function.
"When HIV and morphine combine, the brain becomes stuck in a cycle of ongoing DNA damage and inflammation," Chennakesavan explained.
Existing drug restores repair in laboratory models
Once the researchers understood this damaging cycle, they wondered whether it could be reversed. They tested dimethyl fumarate (DMF), a medication that is already approved to treat multiple sclerosis and is known for its anti-inflammatory and brain-protecting properties.
The results were striking: DMF restored the brain's organization for repairing DNA, calmed harmful immune signaling and improved signs of brain health in laboratory models. Similar positive effects appeared after altering related DNA repair signals.
"What's exciting is that DMF targets the root problem—restoring the brain's natural repair ability—instead of just tamping down inflammation after the damage is done," Thangavel said.
Toward testing in people with HIV
As more people live longer with HIV, keeping their brains healthy becomes a top priority. Furthermore, millions worldwide face not just the challenge of HIV itself, but also added risks from opioid use disorder. This new research connects the dots between HIV, opioids, DNA damage and brain inflammation, suggesting that therapies targeting DNA repair could offer a promising approach beyond current strategies.
"This work gives us a new way to look at HIV-related brain disease," Thangavel said. "Since dimethyl fumarate is already approved for other uses, it's a promising candidate for testing in people with HIV-associated cognitive problems."
The Texas A&M team, with collaborators from the University of Florida and Harvard Medical School, is now expanding its research. They aim to identify early warning signs of DNA damage, test these findings in human tissue and explore new drugs—including DMF—for preserving cognitive function in HIV patients, especially those who use opioids.
"Our ultimate goal is to stop brain decline before it becomes permanent," Thangavel said. "By tackling the root cause of inflammation, we believe millions of people aging with HIV could have a better quality of life."
By showing how HIV and opioids work together to disrupt DNA repair, this study moves beyond treating inflammation itself—it opens the door to therapies that fix the problem where it starts.
Publication details
Karthick Chennakesavan et al., Epigenetic LOCK chromatin links H3K9 modifications to ATM–γH2AX signaling in HIV-Tat and opioid neuroinflammation, Cell Death & Disease (2026). DOI: 10.1038/s41419-026-09146-6
Journal information: Cell Death and Disease
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Researchers find potential way to protect the brain from HIV and opioid damage (2026, November 16) retrieved 16 November 2026 from https://medicalxpress.com/news/2026-11-potential-brain-hiv-opioid.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com